-
The OraQuick in-home HIV-1/2 antibody test was granted market clearance by the FDA on May 15, 2012. Data presented included a < 0.1% false-positive rate and 91.7% sensitivity to correctly detect HIV infection compared to conventional ELISA performed on blood.
-
THE FDA HAS APPROVED A NEW FORMULATION OF PREDNISONE for the treatment rheumatoid arthritis and other conditions in which an anti-inflammatory or immuosuppressive agent is indicated.
-
-
Women with overactive bladder hold differing views of their treatment options in light of the severity of their symptoms as well as the risks/benefits of the modality.
-
CASES OF PANDEMIC H1N1 REQUIRING HOSPITALIZATION were examined by reviewing two national case series from spring and fall 2009
-
The 12-lead ECG shown above was obtained from an older woman who was extremely anxious about her home situation. She felt some "heart sensations." Is she in atrial fibrillation?
-
-
Menopausal hormone therapy and risk of VTE and AD; patients' understanding of chemotherapy benefits; and FDA actions.
-
The left atrial appendage is thought to be the source of a large proportion of emboli in patients with nonvalvular atrial fibrillation. In this paper, Bartus and his colleagues describe an innovative new device that uses a combined transseptal-epicardial approach to ligate the left atrial appendage.
-
The use of non-steroidal anti-inflammatory drugs (NSAIDs) early after myocardial infarction (MI) has been shown to increase the risk of death or recurrent MI, but little is known about the long-term risks.